“Clinical evidence of prospective randomized study catapulted Liberty into high quality trifocal group of IOLs available on the market.”
E. Van Acker, MD(Belgium)
“After over 100 implantations trifocal performance is evident. Less halos & glare, better contrast sensitivity. All my patients implanted with Liberty are spectacle independent.”
J. Győri, MD(Hungary)
“
“Exceptionally good platform and an optic that generates more patient satisfaction in terms of defocus curves and percieved dysphotopsia symptoms. I would not change a thing about this IOL.”
